世界のヒトマイクロバイオーム治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Human Microbiome Therapeutic Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4332 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ヒトマイクロバイオーム治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（FMT、マイクロバイオーム医薬品、その他）、用途別市場規模（胃、口腔、気道、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ヒトマイクロバイオーム治療薬の市場動向 ・企業の競争状況、市場シェア ・ヒトマイクロバイオーム治療薬の種類別市場規模と予測2016-2027（FMT、マイクロバイオーム医薬品、その他） ・ヒトマイクロバイオーム治療薬の用途別市場規模と予測2016-2027（胃、口腔、気道、その他） ・ヒトマイクロバイオーム治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・ヒトマイクロバイオーム治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒトマイクロバイオーム治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒトマイクロバイオーム治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒトマイクロバイオーム治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Rebiotix、Seres Therapeutics、Vedanta Biosciences、Bristol-Myers Squibb、Johnson and Johnson、Takeda、ENTEROME Bioscience） ・結論

Human microbiome therapeutic drugs are drugs made by using the relationship between the gene content of the microbiota and metabolic activities.

Market Analysis and Insights: Global Human Microbiome Therapeutic Drugs Market
The global Human Microbiome Therapeutic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Microbiome Therapeutic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Microbiome Therapeutic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Microbiome Therapeutic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Microbiome Therapeutic Drugs market.

Global Human Microbiome Therapeutic Drugs Scope and Market Size
Human Microbiome Therapeutic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Microbiome Therapeutic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
FMT
Microbiome Drugs
Others

Segment by Application
Stomach
Oral
Respiratory Tract
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson and Johnson
Takeda
ENTEROME Bioscience

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Therapeutic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 FMT
1.2.3 Microbiome Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Microbiome Therapeutic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Stomach
1.3.3 Oral
1.3.4 Respiratory Tract
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Human Microbiome Therapeutic Drugs Market Perspective (2016-2027)
2.2 Human Microbiome Therapeutic Drugs Growth Trends by Regions
2.2.1 Human Microbiome Therapeutic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Microbiome Therapeutic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Human Microbiome Therapeutic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Human Microbiome Therapeutic Drugs Industry Dynamic
2.3.1 Human Microbiome Therapeutic Drugs Market Trends
2.3.2 Human Microbiome Therapeutic Drugs Market Drivers
2.3.3 Human Microbiome Therapeutic Drugs Market Challenges
2.3.4 Human Microbiome Therapeutic Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Therapeutic Drugs Players by Revenue
3.1.1 Global Top Human Microbiome Therapeutic Drugs Players by Revenue (2016-2021)
3.1.2 Global Human Microbiome Therapeutic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Human Microbiome Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Therapeutic Drugs Revenue
3.4 Global Human Microbiome Therapeutic Drugs Market Concentration Ratio
3.4.1 Global Human Microbiome Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Therapeutic Drugs Revenue in 2020
3.5 Human Microbiome Therapeutic Drugs Key Players Head office and Area Served
3.6 Key Players Human Microbiome Therapeutic Drugs Product Solution and Service
3.7 Date of Enter into Human Microbiome Therapeutic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Human Microbiome Therapeutic Drugs Breakdown Data by Type
4.1 Global Human Microbiome Therapeutic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Type (2022-2027)

5 Human Microbiome Therapeutic Drugs Breakdown Data by Application
5.1 Global Human Microbiome Therapeutic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Human Microbiome Therapeutic Drugs Market Size (2016-2027)
6.2 North America Human Microbiome Therapeutic Drugs Market Size by Type
6.2.1 North America Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021)
6.2.2 North America Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027)
6.2.3 North America Human Microbiome Therapeutic Drugs Market Size by Type (2016-2027)
6.3 North America Human Microbiome Therapeutic Drugs Market Size by Application
6.3.1 North America Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021)
6.3.2 North America Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027)
6.3.3 North America Human Microbiome Therapeutic Drugs Market Size by Application (2016-2027)
6.4 North America Human Microbiome Therapeutic Drugs Market Size by Country
6.4.1 North America Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021)
6.4.2 North America Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Human Microbiome Therapeutic Drugs Market Size (2016-2027)
7.2 Europe Human Microbiome Therapeutic Drugs Market Size by Type
7.2.1 Europe Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Human Microbiome Therapeutic Drugs Market Size by Type (2016-2027)
7.3 Europe Human Microbiome Therapeutic Drugs Market Size by Application
7.3.1 Europe Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Human Microbiome Therapeutic Drugs Market Size by Application (2016-2027)
7.4 Europe Human Microbiome Therapeutic Drugs Market Size by Country
7.4.1 Europe Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Type
8.2.1 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Application
8.3.1 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region
8.4.1 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Human Microbiome Therapeutic Drugs Market Size (2016-2027)
9.2 Latin America Human Microbiome Therapeutic Drugs Market Size by Type
9.2.1 Latin America Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Human Microbiome Therapeutic Drugs Market Size by Type (2016-2027)
9.3 Latin America Human Microbiome Therapeutic Drugs Market Size by Application
9.3.1 Latin America Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Human Microbiome Therapeutic Drugs Market Size by Application (2016-2027)
9.4 Latin America Human Microbiome Therapeutic Drugs Market Size by Country
9.4.1 Latin America Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Type
10.2.1 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Application
10.3.1 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country
10.4.1 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Rebiotix
11.1.1 Rebiotix Company Details
11.1.2 Rebiotix Business Overview
11.1.3 Rebiotix Human Microbiome Therapeutic Drugs Introduction
11.1.4 Rebiotix Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
11.1.5 Rebiotix Recent Development
11.2 Seres Therapeutics
11.2.1 Seres Therapeutics Company Details
11.2.2 Seres Therapeutics Business Overview
11.2.3 Seres Therapeutics Human Microbiome Therapeutic Drugs Introduction
11.2.4 Seres Therapeutics Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
11.2.5 Seres Therapeutics Recent Development
11.3 Vedanta Biosciences
11.3.1 Vedanta Biosciences Company Details
11.3.2 Vedanta Biosciences Business Overview
11.3.3 Vedanta Biosciences Human Microbiome Therapeutic Drugs Introduction
11.3.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
11.3.5 Vedanta Biosciences Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Introduction
11.4.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Johnson and Johnson
11.5.1 Johnson and Johnson Company Details
11.5.2 Johnson and Johnson Business Overview
11.5.3 Johnson and Johnson Human Microbiome Therapeutic Drugs Introduction
11.5.4 Johnson and Johnson Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
11.5.5 Johnson and Johnson Recent Development
11.6 Takeda
11.6.1 Takeda Company Details
11.6.2 Takeda Business Overview
11.6.3 Takeda Human Microbiome Therapeutic Drugs Introduction
11.6.4 Takeda Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
11.6.5 Takeda Recent Development
11.7 ENTEROME Bioscience
11.7.1 ENTEROME Bioscience Company Details
11.7.2 ENTEROME Bioscience Business Overview
11.7.3 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Introduction
11.7.4 ENTEROME Bioscience Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
11.7.5 ENTEROME Bioscience Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Human Microbiome Therapeutic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of FMT
Table 3. Key Players of Microbiome Drugs
Table 4. Key Players of Others
Table 5. Global Human Microbiome Therapeutic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Human Microbiome Therapeutic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Human Microbiome Therapeutic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Human Microbiome Therapeutic Drugs Market Share by Regions (2016-2021)
Table 9. Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Human Microbiome Therapeutic Drugs Market Share by Regions (2022-2027)
Table 11. Human Microbiome Therapeutic Drugs Market Trends
Table 12. Human Microbiome Therapeutic Drugs Market Drivers
Table 13. Human Microbiome Therapeutic Drugs Market Challenges
Table 14. Human Microbiome Therapeutic Drugs Market Restraints
Table 15. Global Human Microbiome Therapeutic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Human Microbiome Therapeutic Drugs Market Share by Players (2016-2021)
Table 17. Global Top Human Microbiome Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Therapeutic Drugs as of 2020)
Table 18. Ranking of Global Top Human Microbiome Therapeutic Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Human Microbiome Therapeutic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Human Microbiome Therapeutic Drugs Product Solution and Service
Table 22. Date of Enter into Human Microbiome Therapeutic Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Human Microbiome Therapeutic Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Human Microbiome Therapeutic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Human Microbiome Therapeutic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Human Microbiome Therapeutic Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Human Microbiome Therapeutic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Rebiotix Company Details
Table 63. Rebiotix Business Overview
Table 64. Rebiotix Human Microbiome Therapeutic Drugs Product
Table 65. Rebiotix Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 66. Rebiotix Recent Development
Table 67. Seres Therapeutics Company Details
Table 68. Seres Therapeutics Business Overview
Table 69. Seres Therapeutics Human Microbiome Therapeutic Drugs Product
Table 70. Seres Therapeutics Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 71. Seres Therapeutics Recent Development
Table 72. Vedanta Biosciences Company Details
Table 73. Vedanta Biosciences Business Overview
Table 74. Vedanta Biosciences Human Microbiome Therapeutic Drugs Product
Table 75. Vedanta Biosciences Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 76. Vedanta Biosciences Recent Development
Table 77. Bristol-Myers Squibb Company Details
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Product
Table 80. Bristol-Myers Squibb Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Johnson and Johnson Company Details
Table 83. Johnson and Johnson Business Overview
Table 84. Johnson and Johnson Human Microbiome Therapeutic Drugs Product
Table 85. Johnson and Johnson Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 86. Johnson and Johnson Recent Development
Table 87. Takeda Company Details
Table 88. Takeda Business Overview
Table 89. Takeda Human Microbiome Therapeutic Drugs Product
Table 90. Takeda Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 91. Takeda Recent Development
Table 92. ENTEROME Bioscience Company Details
Table 93. ENTEROME Bioscience Business Overview
Table 94. ENTEROME Bioscience Human Microbiome Therapeutic Drugs Product
Table 95. ENTEROME Bioscience Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 96. ENTEROME Bioscience Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Therapeutic Drugs Market Share by Type: 2020 VS 2027
Figure 2. FMT Features
Figure 3. Microbiome Drugs Features
Figure 4. Others Features
Figure 5. Global Human Microbiome Therapeutic Drugs Market Share by Application: 2020 VS 2027
Figure 6. Stomach Case Studies
Figure 7. Oral Case Studies
Figure 8. Respiratory Tract Case Studies
Figure 9. Others Case Studies
Figure 10. Human Microbiome Therapeutic Drugs Report Years Considered
Figure 11. Global Human Microbiome Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Human Microbiome Therapeutic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Human Microbiome Therapeutic Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Human Microbiome Therapeutic Drugs Market Share by Regions (2022-2027)
Figure 15. Global Human Microbiome Therapeutic Drugs Market Share by Players in 2020
Figure 16. Global Top Human Microbiome Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Therapeutic Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Human Microbiome Therapeutic Drugs Revenue in 2020
Figure 18. Global Human Microbiome Therapeutic Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Human Microbiome Therapeutic Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Human Microbiome Therapeutic Drugs Market Share by Type (2016-2027)
Figure 22. North America Human Microbiome Therapeutic Drugs Market Share by Application (2016-2027)
Figure 23. North America Human Microbiome Therapeutic Drugs Market Share by Country (2016-2027)
Figure 24. United States Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Human Microbiome Therapeutic Drugs Market Share by Type (2016-2027)
Figure 28. Europe Human Microbiome Therapeutic Drugs Market Share by Application (2016-2027)
Figure 29. Europe Human Microbiome Therapeutic Drugs Market Share by Country (2016-2027)
Figure 30. Germany Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Human Microbiome Therapeutic Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Human Microbiome Therapeutic Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Human Microbiome Therapeutic Drugs Market Share by Region (2016-2027)
Figure 40. China Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Human Microbiome Therapeutic Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Human Microbiome Therapeutic Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Human Microbiome Therapeutic Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Human Microbiome Therapeutic Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Human Microbiome Therapeutic Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Human Microbiome Therapeutic Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Human Microbiome Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Rebiotix Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2016-2021)
Figure 60. Seres Therapeutics Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2016-2021)
Figure 61. Vedanta Biosciences Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2016-2021)
Figure 63. Johnson and Johnson Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2016-2021)
Figure 64. Takeda Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2016-2021)
Figure 65. ENTEROME Bioscience Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---